Healthcare AI Firm Sued Over Alleged Unlawful Disclosures of Genetic Data

Steve Alder reports: Tempus AI, a publicly traded healthcare artificial intelligence company, is facing multiple class action lawsuits over the alleged unauthorized collection and disclosure of genetic testing results, which were derived from genetic testing by Ambry Genetics Corporation (Ambry Genetics). Tempus AI used Ambry Genetics’ genetic database to train its AI models. Tempus AI... Source